2027 Co-op Downstream Purification, Analytics, & Bioconjugate Process Development
Regeneron Pharmaceuticals
Summary
Regeneron is currently seeking multiple 2027 Co-ops in Downstream Purification & Bioconjugate Process Development to join our Preclinical Manufacturing and Process Development (PMPD) team, which develops the manufacturing processes used to scale up and produce Regeneron's medicines.
Job description
What you'll do
- Support the purification of medicines using chromatography, filtration, and resin-development techniques
- Develop and qualify new analytical resins and liquid chromatography methods used to evaluate process impurities
- Contribute to chemistry work used to attach drug payloads to antibodies and characterize resulting impurities
- Run small-scale lab experiments to evaluate purification process performance
- Analyze historical process data to identify trends and improvement opportunities
- Collaborate with process scientists and engineers to solve purification challenges
- Document experimental results and contribute to technical reports
- Present findings to the broader development team
Relevant majors
Chemical/Biochemical Engineering, Biochemistry, Biological Sciences
Let's find out if we're a fit
- Must be enrolled in, or accepted to, an academic program pursuing an Undergraduate or Graduate degree (and be returning to school the semester following the position or graduating after the position)
- Must be able to commit to 40 hours per week from January-August, May/June-December, or August-December
- Demonstrated leadership in areas such as campus activities, clubs, sports, current or previous work, or within the community preferred
- Cumulative GPA of 3.0 or higher preferred
Requirements
- Must be enrolled in, or accepted to, an academic program pursuing an Undergraduate or Graduate degree (and be returning to school the semester following the position or graduating after the position)
- Must be able to commit to 40 hours per week from January-August, May/June-December, or August-December
- Demonstrated leadership in areas such as campus activities, clubs, sports, current or previous work, or within the community preferred
- Cumulative GPA of 3.0 or higher preferred
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Insurance benefits
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.